Elsevier

Virus Research

Volume 288, 15 October 2020, 198129
Virus Research

iSCAN: An RT-LAMP-coupled CRISPR-Cas12 module for rapid, sensitive detection of SARS-CoV-2

https://doi.org/10.1016/j.virusres.2020.198129Get rights and content
Under a Creative Commons license
open access

Highlights

  • RT-LAMP coupled with CRISPR-Cas12 provides a sensitive and specific virus detection platform.

  • iSCAN sensitivity and specificity are comparable with RT-qPCR.

  • iSCAN is a 1 h detection module that can help in testing in low resource areas.

  • iSCAN can be developed as a one-pot assay.

  • iSCAN reagents can be produced locally and deployed for SARS-CoV2 detection.

Abstract

The COVID-19 pandemic caused by SARS-CoV-2 affects all aspects of human life. Detection platforms that are efficient, rapid, accurate, specific, sensitive, and user friendly are urgently needed to manage and control the spread of SARS-CoV-2. RT-qPCR based methods are the gold standard for SARS-CoV-2 detection. However, these methods require trained personnel, sophisticated infrastructure, and a long turnaround time, thereby limiting their usefulness. Reverse transcription-loop-mediated isothermal amplification (RT-LAMP), a one-step nucleic acid amplification method conducted at a single temperature, has been used for colorimetric virus detection. CRISPR-Cas12 and CRISPR-Cas13 systems, which possess collateral activity against ssDNA and RNA, respectively, have also been harnessed for virus detection. Here, we built an efficient, rapid, specific, sensitive, user-friendly SARS-CoV-2 detection module that combines the robust virus amplification of RT-LAMP with the specific detection ability of SARS-CoV-2 by CRISPR-Cas12. Furthermore, we combined the RT-LAMP-CRISPR-Cas12 module with lateral flow cells to enable highly efficient point-of-care SARS-CoV-2 detection. Our iSCAN SARS-CoV-2 detection module, which exhibits the critical features of a robust molecular diagnostic device, should facilitate the effective management and control of COVID-19.

Keywords

COVID-19
SARS-CoV-2
RT-LAMP
CRISPR-Cas12
Nucleic acid detection
Biosensors
Diagnostics

Cited by (0)

1

These authors contributed equally: Zahir Ali, Rashid Aman, and Ahmed Mahas.